1f8r: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1f8r.png|left|200px]] | [[Image:1f8r.png|left|200px]] | ||
{{STRUCTURE_1f8r| PDB=1f8r | SCENE= }} | {{STRUCTURE_1f8r| PDB=1f8r | SCENE= }} | ||
===CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE=== | ===CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE=== | ||
{{ABSTRACT_PUBMED_10944103}} | {{ABSTRACT_PUBMED_10944103}} | ||
==About this Structure== | ==About this Structure== | ||
[[1f8r]] is a 4 chain structure of [[Amino acid oxidase]] with sequence from [http://en.wikipedia.org/wiki/Calloselasma_rhodostoma Calloselasma rhodostoma]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1F8R OCA]. | |||
==See Also== | |||
*[[Amino acid oxidase|Amino acid oxidase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:010944103</ref><references group="xtra"/> | ||
[[Category: Calloselasma rhodostoma]] | [[Category: Calloselasma rhodostoma]] | ||
[[Category: L-amino-acid oxidase]] | [[Category: L-amino-acid oxidase]] | ||
| Line 38: | Line 29: | ||
[[Category: Helical domain]] | [[Category: Helical domain]] | ||
[[Category: Oxidase]] | [[Category: Oxidase]] | ||
[[Category: Oxidoreductase]] | |||
Revision as of 12:46, 26 July 2012
CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATECRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE
Template:ABSTRACT PUBMED 10944103
About this StructureAbout this Structure
1f8r is a 4 chain structure of Amino acid oxidase with sequence from Calloselasma rhodostoma. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Pawelek PD, Cheah J, Coulombe R, Macheroux P, Ghisla S, Vrielink A. The structure of L-amino acid oxidase reveals the substrate trajectory into an enantiomerically conserved active site. EMBO J. 2000 Aug 15;19(16):4204-15. PMID:10944103 doi:10.1093/emboj/19.16.4204